NCT03652428 2026-03-02
Phase I Nab-Paclitaxel Plus Gemcitabine With Proton Therapy for Locally Advanced Pancreatic Cancer (LAPC)
University of Maryland, Baltimore
Phase 1/2 Recruiting
Clinical Trials
5 trialsNCT03257033 2025-11-14
TIGeR-PaC
RenovoRx
Phase 3 Recruiting
NCT05653453 2025-03-24
Clinical Study of Tumor Treating Fields Combined with Gemcitabine and Albumin-bound Paclitaxel in the First-line Treatment of Locally Advanced Pancreatic Cancer
Jiangsu Healthy Life Innovation Medical Technology Co., Ltd
Phase 3 Recruiting
NCT05988372 2023-11-01
Surufatinib and Serplulimab Combined With AG Regimen Compare With AG Regimen as Conversion Therapy for Patients With Locally Advanced Pancreatic Cancer (SAGE)
Sun Yat-sen University
Phase 2 Not yet recruiting
NCT01063192 2010-02-05
A Study of Locally Advanced Pancreatic Cancer
National Health Research Institutes, Taiwan
Phase 2 Unknown